United Therapeutics Corporation (UTHR)

NASDAQ: UTHR · Real-Time Price · USD

555.91

+8.76 (1.60%)

At close: Jul 2, 2026, 4:00 PM EDT

555.74

-0.17 (-0.03%)

After-hours: Jul 2, 2026, 7:49 PM EDT

United Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	1,287	1,335	1,195	984.8	727.3	475.8
Depreciation & Amortization	88.4	85.6	72.5	53.2	51.3	49.9
Stock-Based Compensation	149.8	147.7	144	39.1	106.8	138.5
Other Adjustments	75.35	99.7	-88.4	-65.7	58.3	108.2
Change in Receivables	10	-70.9	-0.4	-58.5	-21.7	-41.3
Changes in Inventories	-81.5	-52.6	-46.9	-13.6	-13.4	-7.5
Changes in Accounts Payable	87.8	97.9	42.7	57.1	44.5	-12.5
Changes in Other Operating Activities	-188.4	-80.9	8.5	-18.4	-150.6	-112.9
Operating Cash Flow	1,563	1,561	1,327	978	802.5	598.2
Operating Cash Flow Growth	10.73%	17.64%	35.70%	21.87%	34.15%	-20.84%
Capital Expenditures	-546.4	-520.5	-246.5	-230.4	-138.8	-120.8
Purchases of Intangible Assets	-	-5.5	-	-	-	-
Purchases of Investments	-3,415	-3,460	-1,677	-2,514	-1,710	-1,895
Proceeds from Sale of Investments	4,411	3,446	2,369	2,137	1,037	1,529
Payments for Business Acquisitions	-	-	-	-89.2	-	-
Other Investing Activities	-6.9	-10.4	-28.5	-23	-	-
Investing Cash Flow	357.1	-551.3	417.2	-719.6	-811.5	-486.9
Short-Term Debt Issued	100	200	-	-	800	-
Short-Term Debt Repaid	-400	-500	-400	-100	-800	-
Net Short-Term Debt Issued (Repaid)	-300	-300	-400	-100	0	-
Issuance of Common Stock	235.5	183.1	160.1	104.6	94.3	55.6
Repurchase of Common Stock	-	-1,000	-1,000	-	-	-
Net Common Stock Issued (Repurchased)	235.5	-816.9	-839.9	104.6	94.3	55.6
Other Financing Activities	-67.85	-33.1	-14.9	-16.5	-18.9	-10.8
Financing Cash Flow	-2,541	-1,150	-1,255	-11.9	75.4	44.8
Net Cash Flow	-620.2	-140.1	489.5	246.5	66.4	156.1
Free Cash Flow	1,017	1,041	1,081	747.6	663.7	477.4
Free Cash Flow Growth	-2.29%	-3.69%	44.54%	12.64%	39.02%	-31.45%
FCF Margin	32.08%	32.70%	37.55%	32.12%	34.28%	28.32%
Free Cash Flow Per Share	21.40	21.73	22.28	15.04	13.68	10.09
Levered Free Cash Flow	347.3	564.2	625.4	732.7	520.3	272
Unlevered Free Cash Flow	508.69	691.79	899.6	763.61	542.56	241.56

SEC Filings: 10-K · 10-Q